Vir Biotechnology, Inc.
VIR
$4.60
$0.225.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -550.23M | -577.65M | -521.96M | -533.34M | -483.04M |
| Total Depreciation and Amortization | 11.57M | 12.91M | 14.56M | 16.15M | 17.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 79.72M | 124.78M | 144.37M | 149.62M | 160.46M |
| Change in Net Operating Assets | 1.49M | 24.88M | -83.32M | -99.07M | -146.26M |
| Cash from Operations | -457.45M | -415.08M | -446.35M | -466.64M | -450.99M |
| Capital Expenditure | -8.93M | -7.06M | -7.30M | -6.43M | -7.79M |
| Sale of Property, Plant, and Equipment | 2.79M | 3.12M | 3.37M | 917.00K | 912.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 448.76M | 601.70M | 503.30M | 259.33M | 83.14M |
| Cash from Investing | 442.61M | 597.77M | 499.37M | 253.82M | 76.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 138.00K | 207.00K | 138.00K | 160.00K | 134.00K |
| Issuance of Common Stock | 4.33M | 4.93M | 4.55M | 5.07M | 5.34M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -525.00K | -303.00K | -303.00K | -425.00K | -425.00K |
| Cash from Financing | 3.94M | 4.83M | 4.39M | 4.81M | 5.05M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.90M | 187.52M | 57.40M | -208.02M | -369.68M |